- Home
- BDTX vs CRNX Comparison
BDTX vs CRNX Comparison
Compare BDTX & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BDTX | CRNX |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.8M | 4.5B |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | BDTX | CRNX |
|---|---|---|
| Price | $2.14 | $37.20 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 9 |
| Target Price | $10.40 | ★ $74.78 |
| AVG Volume (30 Days) | 564.6K | ★ 872.2K |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.45 | N/A |
| EPS | ★ 0.65 | N/A |
| Revenue | N/A | ★ $1,039,000.00 |
| Revenue This Year | N/A | $730.30 |
| Revenue Next Year | N/A | $179.48 |
| P/E Ratio | $3.28 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.20 | $24.10 |
| 52 Week High | $4.94 | $57.99 |
Technical Indicators
Market Signals| Indicator | BDTX | CRNX |
|---|---|---|
| Relative Strength Index (RSI) | 40.78 | 28.54 |
| Support Level | $1.93 | $33.23 |
| Resistance Level | $2.67 | $45.32 |
| Average True Range (ATR) | 0.14 | 1.82 |
| MACD | -0.01 | -0.21 |
| Stochastic Oscillator | 26.76 | 19.55 |
Price Performance
Historical ComparisonAbout BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.